Employer profile
Rezolute Inc
20 open roles indexed with location, benefit, and apply-link signals where available.
Open roles
Showing the most recent indexed roles for this employer.
-
Data Analyst II - Commercial Analytics
Redwood City
unspecified $110K-$140KData Analyst II - Commercial Analytics Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin-secreting tumors and related neuro-oncology disorders. More information can be found at rezolutebio.com Position Summary Rezolute is seeking a Data Analyst II to turn complex data into actionable insights supporting commercial planning, medical affairs, and business decision-making. This hands-on role combines data management, coding, analysis, and visualization to help teams better understand patient populations, healthcare providers, treatment patterns, and market opportunities. The Data Analyst II will use AWS, Snowflake, SQL, and Python or R to integrate data, automate analytical workflows, and develop reliable datasets and reporting solutions. Working closely with business stakeholders, this individual will translate questions into structured analyses and communicate findings through clear visualizations, reports, and presentations. The ideal candidate brings strong technical skills, sound analytical judgment, and
-
Director – Biostatistics
Redwood City
unspecified $240K-$310KDirector – Biostatistics Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of congenital and acquired forms of hyperinsulinism (HI). Rezolute's mission is to bring hope and meaningful solutions to patients and families affected by rare diseases through scientific innovation, collaboration, and integrity. Position Summary We are seeking an accomplished Director, Biostatistics to provide strategic and operational leadership for the statistical function within a growing, late-stage biopharmaceutical company. The organization currently has two Phase III clinical programs advancing toward regulatory submissions and commercialization, creating an exciting opportunity for a highly experienced statistician to influence development strategy, regulatory interactions, and submission readiness. The Director, Biostatistics will serve as the lead statistical expert across clinical development programs, partnering closely with Clinical Development, Clinical Operations, Regulatory Affairs, Medical Affairs, Pharmacovigilance, Statistical Programming, and external vendors. This individual will ensure the design, analysis, interpretation, and reporting of clinical trial data meet the highest scientific and regulatory standards. Experience in rare disease drug development and NDA/BLA submissions is strongly preferred. Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of congenital and acquired forms of hyperinsulinism (HI). Rezolute's mission
-
Medical Science Liaison / Senior Medical Science Liaison - Oncology / Rare Endocrine Disorders
Remote
remote $185K-$240KMedical Science Liaison / Senior Medical Science Liaison - Oncology / Rare Endocrine Disorders Remote Location: Regionally US-Based- Multiple Regions/Positions Open Therapeutic Area: Oncology / Rare Endocrine Disorders Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of congenital and acquired forms of hyperinsulinism (HI). Rezolute's mission is to bring hope and meaningful solutions to patients and families affected by rare diseases through scientific innovation, collaboration, and integrity. As part of a newly established Medical Affairs team, the Medical Science Liaison (MSL) serves as a critical scientific bridge between the company and the external healthcare community, supporting scientific engagement and launch readiness ahead of multiple indication launches planned over the next 2-4 years. The MSL is responsible for developing and strengthening professional relationships with medical thought leaders across rare endocrine and oncologic diseases. Through scientific exchange, the MSL provides medical information and clinical/scientific support to advance Rezolute's Medical Affairs objectives. This position requires an individual with established professional and scientific credibility who can effectively engage with global thought leaders and academic centers of excellence. The MSL is expected to represent Rezolute with the highest professional and ethical standards, in accordance with company policies, applicable industry guidelines, and the mission and values of the Medical Affairs organization. Location: Regionally US-Based- Multiple Regions/Positions Open Therapeutic Area: Oncology / Rare Endocrine
-
Medical Science Liaison / Senior Medical Science Liaison - Pediatric Endocrinology / Rare Metabolic Disorders
Remote
remote $185K-$240KMedical Science Liaison / Senior Medical Science Liaison - Pediatric Endocrinology / Rare Metabolic Disorders Remote Location: Regionally US-Based- Multiple Regions/Positions Open Therapeutic Area: Pediatric Endocrinology / Rare Metabolic Disorders Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of congenital and acquired forms of hyperinsulinism (HI). Rezolute's mission is to bring hope and meaningful solutions to patients and families affected by rare diseases through scientific innovation, collaboration, and integrity. As part of a newly established Medical Affairs team, the Medical Science Liaison (MSL) serves as a critical scientific bridge between the company and the external healthcare community, supporting scientific engagement and launch readiness ahead of multiple indication launches planned over the next 2-4 years. The MSL is responsible for developing and strengthening professional relationships with medical thought leaders across rare endocrine and metabolic diseases. Through scientific exchange, the MSL provides medical information and clinical/scientific support to advance Rezolute's Medical Affairs objectives. This position requires an individual with established professional and scientific credibility who can effectively engage with global thought leaders and academic centers of excellence. The MSL is expected to represent Rezolute with the highest professional and ethical standards, in accordance with company policies, applicable industry guidelines, and the mission and values of the Medical Affairs organization. Location: Regionally US-Based- Multiple Regions/Positions Open Therapeutic Area: Pediatric Endocrinology
-
Recruiting Coordinator & Scheduler – 6 month contract
Redwood City
unspecified $40-$60/hrRecruiting Coordinator & Scheduler – 6 month contract Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of congenital and acquired forms of hyperinsulinism (HI). Rezolute's mission is to bring hope and meaningful solutions to patients and families affected by rare diseases through scientific innovation, collaboration, and integrity. Position Overview : As a Recruiting Coordinator & Scheduler, you will support Talent Acquisition operations. You will manage complex interview schedules, coordinate high-touch candidate experiences, and ensure seamless logistics throughout the hiring pipeline. Working closely with hiring managers, scientific leaders, and talent acquisition teams, you will represent our employer brand to candidates and help maintain a high standard of candidate care. This is a hybrid contract position requiring onsite presence three days per week . Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of congenital and acquired forms of hyperinsulinism (HI). Rezolute's mission is to bring hope and meaningful solutions to patients and families affected by rare diseases through scientific innovation, collaboration, and integrity. Position Overview : As a Recruiting Coordinator & Scheduler, you will support Talent Acquisition operations. You will manage complex interview schedules,
-
Contract Recruiter (Biopharmaceutical Industry) 6 month contract
Redwood City
unspecified $65-$90/hrContract Recruiter (Biopharmaceutical Industry) 6 month contract Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Position Summary We are seeking an experienced Contract Recruiter for a 6 month contract to join our rapidly growing biopharmaceutical company during an exciting phase of expansion. This individual will play a critical role in attracting, engaging, and hiring top talent across a variety of functions, including Clinical Development, Regulatory Affairs, Medical Affairs, Biometrics, Research, CMC, Quality, Commercial, and Corporate Operations. The ideal candidate brings a strong track record of full-cycle recruiting and sourcing within the biotechnology and pharmaceutical industries, is highly skilled at proactive sourcing and candidate engagement, and thrives in a fast-paced, high-growth environment. This role requires a hands-on recruiter who is equally comfortable developing talent pipelines, managing candidate relationships, and coordinating a seamless interview process. This is a hybrid contract position requiring onsite presence three days per week . Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Position Summary We are seeking an experienced Contract Recruiter for a 6 month contract to
-
Senior Manager, Scientific Communications & Medical Education
Redwood City
unspecified $180K-$225KSenior Manager, Scientific Communications & Medical Education Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage development for hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI), including congenital hyperinsulinism (cHI), the most common cause of persistent hypoglycemia in infants and children. The Senior Manager, Scientific Communications & Medical Education will develop and manage Rezolute's core scientific content and medical review activities for RZ358 across congenital and tumor HI. Key responsibilities include standard response document (SRD) development, in-house Medical Information, medical review in MLR/PRC, medical education grant management, Scientific Communication Platform (SCP) coordination, and MSL slide deck development. The Senior Manager will partner with MSLs, Medical Affairs Core Services, and cross-functional colleagues, and will report to the Director, Scientific Communications & Medical Education. Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage development for hypoglycemia due to congenital and acquired forms of hyperinsulinism
-
Head of Product Launch Program Management (Rare Disease)
Redwood City
unspecified $240K-$290KHead of Product Launch Program Management (Rare Disease) Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin-secreting tumors and related neuro-oncology disorders. More information can be found at rezolutebio.com The Director, Product Launch Program Management is a member of the Program Management Office (PMO), reporting to the Senior Vice President, Operations, and directly supporting the Commercial Product Launch Lead (Head of Marketing). The PLPM owns the integrated launch plan by indication and by market across the U.S. and priority ex-U.S. countries, and facilitates, consolidates, organizes, documents, and measures that plan so the Product Launch Lead and functional leaders can make decisions and deliver against it. The role supports establishment of the launch strategy with specific responsibility to make it complete, current, and executable. Working within the company's governance model, the role works daily within
-
Associate Director, Medical Affairs Operations
Redwood City
unspecified $195K-$225KAssociate Director, Medical Affairs Operations Redwood City Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Our antibody therapy, RZ358 (ersodetug), is designed to treat all forms of HI and has shown substantial benefit in clinical trials and real-world use for the treatment of congenital hyperinsulinism (cHI) and tumor hyperinsulinism (tumor HI). The Associate Director, Medical Affairs Operations will play a key role in supporting the implementation, coordination, and ongoing management of Medical Affairs operational capabilities, processes, systems, and infrastructure to enable effective execution of Medical Affairs strategies and initiatives. Reporting to the Executive Director, Medical Affairs Strategy & Operations, this individual will translate established Medical Affairs priorities into operational plans, processes, and deliverables supporting pre-launch, launch, post-launch, and future pipeline activities. The position will support the Executive Director in advancing Medical Affairs operational capabilities, infrastructure, governance, and launch readiness, while maintaining alignment with functional leadership on priorities, resource allocation, and key operational decisions. The successful candidate will combine strong project management skills, operational expertise, initiative, and attention to detail with the ability to independently manage assigned responsibilities and collaborate effectively across functions. This individual will contribute to building scalable Medical Affairs infrastructure and operational processes appropriate for Rezolute's evolution into a commercial-stage organization. Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Our antibody therapy, RZ358 (ersodetug), is designed to treat all forms of HI and has
-
Vice President, Global Manufacturing
Redwood City
unspecified $290K-$340KVice President, Global Manufacturing Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). Position Description: Overview A key member of Rezolute's Technical Operations Leadership team, the Vice President, Global Manufacturing has the mandate to provide the vision, leadership, strategy and management skills to build, lead and oversee Rezolute's fully externalized, global biologics manufacturing network, from cell line through Drug Product. The role is accountable for the reliable, robust and redundant manufacture of ersodetug in support of late-phase clinical supply, global submissions, approval, launch and continuous commercial supply. The Vice President, Global Manufacturing will build and lead executive-level relationships across the global service provider network, engaging both at the Site Head level and with above-site executive leadership to influence and resolve capability, capacity, reliability and readiness. The position reports to the Senior Vice President, Operations (and Head of Technical Operations), and works daily in partnership with the Head of Quality and the Vice President, Global Supply Chain to deliver one seamless manufacture and supply platform, while acting as a pivotal source of information for the RZLT Management Team and Board of
-
Vice President, Global Supply Chain
Redwood City
unspecified $290K-$340KVice President, Global Supply Chain Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). Position Description: Overview A key member of Rezolute's Technical Operations Leadership team, the Vice President, Global Supply Chain has the mandate to provide the vision, leadership, strategy and management skills to build, lead and oversee Rezolute's global clinical and commercial supply chain, from storage of Drug Product once shipped from the manufacturing site through labeling, packaging, Finished Drug Product (FDP), regional and country depots, 3PL operations and distribution channels to clinical sites, global patients and partners. The role owns the S&OP process and the FDP supply plan to global channels, and the ERP inventory management system that supports them. This role is forward facing as a member of the Launch Team and works closely with Commercial, Commercial Patient Services, Regulatory and the ex-US Commercial and Regulatory teams to define the final label, artwork and product packaging configuration supporting country-by-country market entry and supply. The position reports to the Senior Vice President, Operations (and Head of Technical Operations), and works daily in partnership with the Head of
-
Medical Writer II, Clinical/Regulatory
Redwood City
unspecified $110K-$135KMedical Writer II, Clinical/Regulatory Redwood City Location: Redwood City, California Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Our antibody therapy, RZ358 (ersodetug), is designed to treat all forms of HI and has shown substantial benefit in clinical trials and real-world use for the treatment of congenital hyperinsulinism (cHI) and tumor hyperinsulinism (tHI). We are seeking an experienced and detail-oriented Medical Writer II to join our dynamic team. In this role, you will be responsible for developing high-quality, scientifically accurate, and regulatory-compliant documents for clinical trials, regulatory submissions and medical affairs. Interfaces with cross-functional groups to ensure accurate and timely completion/delivery of information and review of writing projects. You will collaborate with cross-functional teams, including clinical researchers, regulatory professionals, and subject matter experts, to produce materials that support the advancement of clinical trials, product development, and regulatory submissions. The Medical Writer II serves as medical writing lead on assigned projects. Works closely with in-function and cross-functional team(s) on project strategies. Implements all activities related to the preparation of writing projects. Coordinates the review, approval, and other appropriate functions involved in the production of writing projects. Negotiates with functional areas on project outcomes and deliverables to meet conflicting demands. Identifies and proposes solutions to resolve issues and questions arising during the writing process, including resolution or elevation as appropriate. Arranges and conducts review meetings with the team. Ensures required documentation is obtained. Location: Redwood City, California Rezolute is a
-
Executive & Administrative Business Partner
Redwood City
onsite $110K-$145KExecutive & Administrative Business Partner Redwood City Location : Redwood City, California (onsite 4 days per week required) Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Our antibody therapy, RZ358 (ersodetug), is designed to treat all forms of HI and has shown substantial benefit in clinical trials and real-world use for the treatment of congenital hyperinsulinism (cHI) and tumor hyperinsulinism (tHI). We are a rapidly growing small clinical stage biopharmaceutical company headquartered in Redwood City, California. We are seeking an experienced office administration professional to provide support to this office and other remote employees as needed The Executive & Administrative Business Partner reports to the Vice President of People & Culture and provides primary high-quality administrative and office operations support. They will be professional, attentive to details, effective in communications and management of interactions with external partners and personnel in other departments of the company. The successful candidates will have excellent customer service and be outcome oriented. The ability to work in a fast-paced environment with strong attention to detail is essential. Location : Redwood City, California (onsite 4 days per week required) Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Our antibody therapy, RZ358 (ersodetug), is designed to treat all forms of HI and has shown substantial benefit in clinical trials and real-world use for the treatment of congenital hyperinsulinism (cHI) and tumor hyperinsulinism (tHI).
-
Director / Senior Director, Pharmacovigilance Operations
Remote
remote $255K-$315KDirector / Senior Director, Pharmacovigilance Operations Remote Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin-secreting tumors and related neuro-oncology disorders More information can be found at rezolutebio.com The Director / Senior Director, PharmacovigilanceOperations will play a critical leadership role in building and executing the company's pharmacovigilance and drug safety capabilities as the organization advances its lead product toward regulatory approval and commercial launch. This individual will be responsible for ensuring an effective, scalable, and inspection-ready pharmacovigilance system supporting late-stage clinical development, regulatory submissions, product launch, and post-marketing safety surveillance. The role will provide leadership across safety operations, benefit-risk management, signal detection and management, aggregate reporting, safety governance, vendor oversight, and global regulatory compliance. As the company evolves from a development-stage organization to a commercial biopharmaceutical company, the Director/Senior Director will help establish the people, processes,
-
Senior Manager, External Supplier Operations
Redwood City
unspecified $165K-$180KSenior Manager, External Supplier Operations Redwood City Rezolute is a pre-commercial ultra-rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Our antibody therapy, RZ358 (ersodetug), is designed to treat all forms of HI and has shown substantial benefit in clinical trials and real-world use for the treatment of congenital hyperinsulinism (cHI) and tumor hyperinsulinism (tHI). Rezolute is seeking a proactive, self-directed professional to support its late-stage and pre-commercial external manufacturing operations. The Senior Manager, External Supplier Operations will support the execution and oversight of external manufacturing programs, with a focus on supplier coordination, technology transfer, manufacturing readiness, and delivery of critical program milestones. This role will establish and maintain the operating cadence required to ensure external supplier activities remain aligned with Rezolute's Plan of Record (POR), program timelines, supply requirements, and business priorities. The individual will manage schedules, dependencies, deliverables, risks, and action items; facilitate internal and external meetings; and provide clear visibility to program status and emerging issues. The successful candidate will have experience working with contract development and manufacturing organizations (CDMOs) and managing external manufacturing programs from an operational and project execution perspective. A strong knowledge of biopharmaceutical manufacturing is important to enable informed communication and effective coordination with technical SMEs, although this role is not intended to serve as the primary technical subject matter expert. The individual will work closely with Manufacturing Operations, MSAT, QA, Supplier Relationship Management (SRM), Business stakeholders, Supply Chain, Procurement, and external suppliers to ensure effective
-
Sr Director, Regulatory Affairs
Redwood City
unspecified Salary not disclosedSr Director, Regulatory Affairs Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin-secreting tumors and related neuro-oncology disorders. Position Summary Reporting to the Chief Regulatory Officer, the Sr Director of Regulatory Affairs will join the regulatory team providing strategic and operational leadership supporting late-stage clinical development through regulatory submission, approval, and product launch. This individual will serve as a key member of the project team and provide regulatory support for strategy implementation across the functions with a primary focus on FDA interactions and U.S. registration. The ideal candidate brings deep expertise in rare disease regulatory pathways and biologics development, including experience in endocrinology, metabolic, and oncology programs. This leader will have a strong understanding of CMC considerations for biologics and experience navigating complex regulatory requirements associated with BLA submissions. The candidate will have experience
-
Sr. Director, Commercial Supply Chain
Redwood City
unspecified $225K-$280KSr. Director, Commercial Supply Chain Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin-secreting tumors and related neuro-oncology disorders Position Summary The Sr.Director, Commercial Supply Chain will lead supply chain strategy and operations as Rezolute transitions from late-stage clinical development to commercial launch. This individual will establish scalable, compliant, and efficient supply capabilities to ensure uninterrupted supply of investigational and commercial products across global markets. The role requires a strategic, hands-on leader who can design the future-state operating model, build critical systems and partnerships, and lead a growing team through commercialization while supporting ongoing clinical supply operations. Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by
-
Vice President, Commercial Operations (Tumor HI Program)
Redwood City
unspecified $300K-$360KVice President, Commercial Operations (Tumor HI Program) Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin-secreting tumors and related neuro-oncology disorders. Position Summary We are seeking a dynamic and experienced Vice President of Commercial Operations to establish and lead all operational aspects of our commercial strategy in support of the launch of our first rare disease therapy. This includes managing commercial operations functions ensuring the infrastructure, processes, and strategies necessary for successful product launch. This individual will be a strategic and hands-on leader responsible for building and managing critical commercial infrastructure, including sales operations, analytics, forecasting, market access operations, and commercial systems. This role oversees sales operations, forecasting and analytics, incentive compensation, market research, data management, CRM systems, field effectiveness, and commercial training. The ideal candidate has experience in rare disease or specialty pharmaceutical
-
Executive Director, Payer Strategy and Engagement (Tumor HI Program)
Redwood City
unspecified $290K-$320KExecutive Director, Payer Strategy and Engagement (Tumor HI Program) Redwood City Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin-secreting tumors and related neuro-oncology disorders. Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute's lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI), most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies
-
Associate Director, Quality Control
Redwood City
unspecified $185K-$200KAssociate Director, Quality Control Redwood City Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Our antibody therapy, RZ358 (ersodetug), is designed to treat all forms of HI and has shown substantial benefit in clinical trials and real-world use for the treatment of congenital hyperinsulinism (cHI) and tumor hyperinsulinism (tHI) Position Description This position is responsible for management of Rezolute's clinical and commercial product testing program. The Associate Director, Quality Control acts as a liaison between Rezolute and its contract test laboratory (CTL) / CMO partners who perform our release and stability testing. The successful candidate will support Rezolute's objectives by acting as a Quality Control subject matter expert during internal stakeholder collaborations and external team meetings. Principle Duties and Responsibilities Include: Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). Our antibody therapy, RZ358 (ersodetug), is designed to treat all forms of HI and has shown substantial benefit in clinical trials and real-world use for the treatment of congenital hyperinsulinism (cHI) and tumor hyperinsulinism (tHI) Position Description This position is responsible for management of Rezolute's clinical and commercial product testing program. The Associate Director, Quality Control acts as a liaison between Rezolute and its contract test laboratory (CTL) / CMO partners who perform our release and stability testing. The successful candidate will support Rezolute's objectives by acting as a Quality Control subject matter expert during internal stakeholder